基于埃沃胺的酸还原酶响应性治疗结肠癌治疗的治疗药物
Keliang Li1, Yuhang Sun1, Zonglin Ma2
1The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Second Military Medical University (Naval Medical University), Shanghai 200433, China.
Journal of medicinal chemistry
|April 2, 2025
概括
新的治疗药物通过在低氧环境中激活前药物来向固体瘤. 在临床前模型中,Probe-2在低毒性下显示出显著的瘤生长抑制.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 低氧是一种低氧状态,在固体瘤中普遍存在,并且经常与缩酶 (NTR) 过度表达相关.
- 瘤中的NTR过度表达为前药激活提供了治疗标,使局部药物输送和增强抗瘤效果成为可能.
研究的目的:
- 开发基于evodiaamine的新型治疗药物,用于低氧向癌症治疗.
- 通过NTR介导激活,实现同时进行瘤成像和治疗剂释放.
主要方法:
- 设计和合成由氧还原酶 (NTR) 激活的以埃沃胺为基础的前药物.
- 选择性NTR介导激活,光特性和抗瘤疗效在体外和体外的评估.
- 在HCT116异种移植裸体小鼠中评估Probe-2的抗瘤活性和毒性.
主要成果:
- 开发的治疗药物被NTR选择性激活,显示出出色的光和抗瘤功效.
- 探针-2在HCT116异种移植中表现出显著的体内抗瘤活性,瘤生长抑制 (TGI) 为76.1%.
- 这些药物表现出有利的瘤向性质和低系统毒性.
结论:
- 响应NTR的治疗药剂为低氧向癌症治疗提供了一个有前途的平台.
- 这些药物促进前药物激活,使同时监测和释放治疗物质成为可能.
- 基于埃沃迪胺的治疗药物显示出增强可控药物释放的固体瘤抗瘤疗效的潜力.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
144
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
144
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
161
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
161
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
199
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
199
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)